RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ILARIUCCI F
Collezione AOU Novara

Items : 8

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia. in American journal of hematology / Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17.

2023
AOU Novara

Morabito F; Tripepi G; Mauro FR; Laurenti L; Reda G; Moia R; Condoluci A; Vincelli I; Chiarenza A; Vigna E; Martino EA; Bruzzese A; Mezzatesta S; Laureana R; Cutrona G; Di Raimondo F; Fronza G; Zucchetto A; Bomben R; Rossi FM; Olivieri J; Zaja F; Rossi D; Gaidano G; Del Principe MI; Ilariucci F; Del Poeta G; Ferrarini M; Neri A; et alii...

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. in Leukemia / Leukemia. 2023 Feb;37(2):433-440. doi: 10.1038/s41375-022-01780-1. Epub 2023 Jan 18.

2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Pileri SA; Corradini P; Carniti C; Ciccone G; Tucci A; Boccomini C; Bermema A; Magagnoli M; Cavallo F; Leonardi F; Arcaini L; Patti C; Ballerini F; Musuraca G; Bruna R; Benedetti F; Volpetti S; Flenghi L; Celli M; Zilioli VR; Ilariucci F; Arcari A; Rossi FG; Zanni M; Ciancia R; Ghiggi C; Pinto A; Stefoni V; Usai SV; et alii...

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5.

2021
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Novak U; Osborne W; Frezzato M; Fox CP; Davies A; Cascavilla N; Bernardi M; Gastaldi E; Cozens K; Bromberg JEC; Singh V; Fanni A; Re F; Patti C; McKay P; Olivieri J; Linton K; Nassi L; Cellini C; Botto B; Cattaneo C; Khwaja J; Luppi M; Calimeri T; Doorduijn JK; Re A; Cabras MG; Smith J; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years. in Neurology / Neurology. 2014 Apr 15;82(15):1370-3. doi: 10.1212/WNL.0000000000000314. Epub 2014 Mar 14.

2014
AOU Novara

Ciceri F; Brandes AA; Montanari M; Balzarotti M; Ferreri AJ; Spina M; Ilariucci F; Zaja F; Stelitano C; Bobbio F; Corazzelli G; Baldini L; Reni M;

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13.

2013
AOU Novara

Massucco C; Recchia AG; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Mosca L; Morabito F; Colombo M; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; et alii...